DNA X, Inc. Operating Income Loss

• DNA X, Inc. showed a decrease of -6,657.3% in Operating Income Loss from 2023 to 2024.
• This data is from DNA X, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
• XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2018 to 2024), DNA X, Inc.'s Operating Income Loss has declined by 723.6%.
• Historical annual values: Fiscal year 2024: -$33.64 million | Fiscal year 2023: $513.0 thousand | Fiscal year 2022: -$14.29 million | Fiscal year 2021: -$38.00 million | Fiscal year 2020: -$29.26 million | Fiscal year 2019: -$22.38 million | Fiscal year 2018: $5.39 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026